A Texas judge ruled that the Food and Drug Administration wrongly approved mifepristone in 2000 and accused it of doing a rush job. Here’s what really went down.
As the debate over mifepristone makes its way to the Supreme Court, the pharmaceutical industry has raised concerns that ruling against the FDA could chill the development of new drugs.
The Department of Health and Human Services will propose an amended definition of “lawful presence” to include recipients of the Deferred Action for Childhood Arrivals program, the White House said.
The end-of-life benefit costs billions a year. A new approach aims to eliminate waste and weed out bad actors, while making the care more inviting to those who most need it.
The mifepristone ruling in Texas has been met with concern from the pharmaceutical industry, who say the decision, if upheld, could having a chilling effect on the development of new drugs.
Medical residents at Penn Medicine in Philadelphia move to unionize in search of better working conditions. (This piece originally aired April 4, 2023, on All Things Considered.)
The start of pregnancy — as well as exactly when that happens — is a hot topic in some state legislatures and U.S. courts. Understanding the nuances of what happens when has never been more important.
Paying taxes can be agonizing. So can shopping for health insurance. But a handful of states have made enrolling in subsidized or free coverage a little easier for people when they file their taxes
States can once again begin removing people from their Medicaid rolls. It’s estimated that about 15 million people could lose their coverage in the coming months, including many who remain eligible.